![Nancy Thomason](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nancy Thomason
Chairman at Promedior, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Mohamed Genead | M | - |
Aviceda Therapeutics, Inc.
![]() Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | - |
Michael Tolentino | M | - |
Aviceda Therapeutics, Inc.
![]() Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | - |
Derek Kunimoto | M | - |
Aviceda Therapeutics, Inc.
![]() Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | - |
Amir Hasid | M | - |
HAP Investments LLC
![]() HAP Investments LLC Real Estate DevelopmentFinance HAP Investments LLC acquires and develops mid sized residential and commercial properties. The firm specializes in global real estate markets, property development, real estate finance and law. The company was founded by Eran Polack, Amir Hasid, and Nir Amsel in 2010 and is headquartered in New York, NY. | 14 years |
Richard Jack | M | - |
Promedior, Inc.
![]() Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | 10 years |
Graham Schillmoller | M | - |
Parata Systems LLC
![]() Parata Systems LLC Industrial MachineryProducer Manufacturing Parata Systems LLC engages in the provision of pharmacy technology solutions. It offers pharmacy automation, medication management, pharmacy workflow integration, medication packaging, and long term care medication solutions. The company was founded by Jess Eberdt and W. L. Townsend in 2001 and is headquartered in Durham, NC. | 20 years |
Eran Polack | M | - |
HAP Investments LLC
![]() HAP Investments LLC Real Estate DevelopmentFinance HAP Investments LLC acquires and develops mid sized residential and commercial properties. The firm specializes in global real estate markets, property development, real estate finance and law. The company was founded by Eran Polack, Amir Hasid, and Nir Amsel in 2010 and is headquartered in New York, NY. | 14 years |
Richard Bucala | M | - |
Promedior, Inc.
![]() Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | - |
Paul Vukelic | M | - |
Aviceda Therapeutics, Inc.
![]() Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | - |
John H. Friedman | M | 71 |
Promedior, Inc.
![]() Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | - |
Augustine Lawlor | M | 67 |
Promedior, Inc.
![]() Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | - |
Patrick Johnson | M | - |
Aviceda Therapeutics, Inc.
![]() Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | 1 years |
W. Scott Willett | M | - |
Promedior, Inc.
![]() Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | 17 years |
Richard Maroun | M | 69 |
Parata Systems LLC
![]() Parata Systems LLC Industrial MachineryProducer Manufacturing Parata Systems LLC engages in the provision of pharmacy technology solutions. It offers pharmacy automation, medication management, pharmacy workflow integration, medication packaging, and long term care medication solutions. The company was founded by Jess Eberdt and W. L. Townsend in 2001 and is headquartered in Durham, NC. | - |
Geert-Jan Mulder | M | 58 |
Promedior, Inc.
![]() Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | - |
Howard Weisman | M | 64 |
Promedior, Inc.
![]() Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | 11 years |
Christoph Adams | M | 67 |
Aviceda Therapeutics, Inc.
![]() Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | 4 years |
Chet Coates | M | - |
Parata Systems LLC
![]() Parata Systems LLC Industrial MachineryProducer Manufacturing Parata Systems LLC engages in the provision of pharmacy technology solutions. It offers pharmacy automation, medication management, pharmacy workflow integration, medication packaging, and long term care medication solutions. The company was founded by Jess Eberdt and W. L. Townsend in 2001 and is headquartered in Durham, NC. | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Kfir M. Ribak | M | - |
HAP Investments LLC
![]() HAP Investments LLC Real Estate DevelopmentFinance HAP Investments LLC acquires and develops mid sized residential and commercial properties. The firm specializes in global real estate markets, property development, real estate finance and law. The company was founded by Eran Polack, Amir Hasid, and Nir Amsel in 2010 and is headquartered in New York, NY. | - |
Moran Sellam | F | - |
HAP Investments LLC
![]() HAP Investments LLC Real Estate DevelopmentFinance HAP Investments LLC acquires and develops mid sized residential and commercial properties. The firm specializes in global real estate markets, property development, real estate finance and law. The company was founded by Eran Polack, Amir Hasid, and Nir Amsel in 2010 and is headquartered in New York, NY. | 5 years |
Bess Sobota | F | - |
HAP Investments LLC
![]() HAP Investments LLC Real Estate DevelopmentFinance HAP Investments LLC acquires and develops mid sized residential and commercial properties. The firm specializes in global real estate markets, property development, real estate finance and law. The company was founded by Eran Polack, Amir Hasid, and Nir Amsel in 2010 and is headquartered in New York, NY. | - |
Patrick Healy | M | - |
Aviceda Therapeutics, Inc.
![]() Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 22 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Nancy Thomason
- Personal Network